These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11952922)

  • 1. Beneficial effects of tandospirone on ataxia of a patient with Machado-Joseph disease.
    Takei A; Honma S; Kawashima A; Yabe I; Fukazawa T; Hamada K; Hamada T; Tashiro K
    Psychiatry Clin Neurosci; 2002 Apr; 56(2):181-5. PubMed ID: 11952922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tandospirone on "5-HT1A receptor-associated symptoms" in patients with Machado-Josephe disease: an open-label study.
    Takei A; Fukazawa T; Hamada T; Sohma H; Yabe I; Sasaki H; Tashiro K
    Clin Neuropharmacol; 2004; 27(1):9-13. PubMed ID: 15090930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new approach to innovating selective anxiolytics: pharmacological profile of a novel 5-HT1A agonist (tandospirone)].
    Sasa M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):53-9. PubMed ID: 9201724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of cerebellar ataxia with 5-HT1A agonist.
    Takei A; Hamada T; Yabe I; Sasaki H
    Cerebellum; 2005; 4(3):211-5. PubMed ID: 16147954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of the serotonergic anxiolytic tandospirone (SM-3997).
    Seymour PA; Mena EE; McLean S; Heym J
    Prog Clin Biol Res; 1990; 361():453-60. PubMed ID: 1981263
    [No Abstract]   [Full Text] [Related]  

  • 6. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
    Evans SM; Troisi JR; Griffiths RR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Drug holiday' effects of tandospirone in a patient with Machado-Joseph disease.
    Takei A; Fukazawa T; Hamada T; Yabe I; Tashiro K
    Psychiatry Clin Neurosci; 2003 Dec; 57(6):607-8. PubMed ID: 14629711
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior.
    Murata Y; Yanagihara Y; Mori M; Mine K; Enjoji M
    J Affect Disord; 2015 Jul; 180():1-9. PubMed ID: 25879718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandospirone-induced K+ current in acutely dissociated rat dorsal raphe neurones.
    Jin YH; Akaike N
    Br J Pharmacol; 1998 Jul; 124(5):897-904. PubMed ID: 9692774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacology of anxiolytics and their therapeutic use].
    Tada K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):608-11. PubMed ID: 12877061
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial.
    Yamada K; Yagi G; Kanba S
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):183-7. PubMed ID: 12667165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
    Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
    Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of serotonin 1A agonist tandospirone on depression symptoms in senile patients with dementia.
    Masuda Y; Akagawa Y; Hishikawa Y
    Hum Psychopharmacol; 2002 Jun; 17(4):191-3. PubMed ID: 12404687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tandospirone, a 5-HT1A receptor-related anxiolytic, on the pressor response elicited by stimulation of the posterior hypothalamus in cats.
    Tsuji R; Ohno Y; Hirose A; Shimizu H; Tanaka H; Nakamura M
    Arch Int Pharmacodyn Ther; 1991; 311():131-43. PubMed ID: 1686389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tandospirone citrate, a selective 5-HT1A agonist, alleviates L-DOPA-induced dyskinesia in patients with Parkinson's disease].
    Kannari K; Kurahashi K; Tomiyama M; Maeda T; Arai A; Baba M; Suda T; Matsunaga M
    No To Shinkei; 2002 Feb; 54(2):133-7. PubMed ID: 11889759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of blepharospasm with tandospirone, a 5-HT1A partial agonist: a case report.
    Takahashi T; Murata T; Wada Y
    Mov Disord; 2008 Jan; 23(1):151-2. PubMed ID: 17987656
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of anxiolytics, diazepam and tandospirone, on immobilization stress-induced hyperglycemia in mice.
    Sugimoto Y; Yamada J; Noma T
    Life Sci; 1998; 63(14):1221-6. PubMed ID: 9771911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors.
    Mulroney SE; Skudlarek C; Shemer A; Lumpkin MD; Kellar KJ
    J Pharmacol Exp Ther; 1994 Feb; 268(2):862-7. PubMed ID: 8113999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and pharmacodynamics of tandospirone in rats exposed to conditioned fear stress.
    Nishitsuji K; To H; Shimizu T; Yanase Y; Yamada T; Hara C; Mine K; Higuchi S
    Eur Neuropsychopharmacol; 2006 Jul; 16(5):376-82. PubMed ID: 16406508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rat brain concentrations of monoamines and their metabolites after chronic administration of diazepam and tandospirone].
    Nishikouri Y; Ikeda R; Kubodera K; Taniguchi M; Hikiba S; Kondoh M; Ikeuchi N; Shimizu M; Miura S
    Yakubutsu Seishin Kodo; 1992 Feb; 12(1):9-15. PubMed ID: 1357841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.